Cargando…

Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma

Sorrell AD, Lee S, Stolle C, Ellenhorn J, Grix A, Kaelin Jr WG, Weitzel JN. Clinical and functional properties of novel VHL mutation (X214L) consistent with Type 2A phenotype and low risk of renal cell carcinoma. This report describes clinical characteristics in families with a Type 2A phenotype and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorrell, AD, Lee, S, Stolle, C, Ellenhorn, J, Grix, A, Kaelin, WG, Weitzel, JN
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958253/ https://www.ncbi.nlm.nih.gov/pubmed/20560986 http://dx.doi.org/10.1111/j.1399-0004.2010.01464.x

Ejemplares similares

Determination of the consequences of VHL mutations on VHL transcripts in renal cell carcinoma
por: TAYLOR, CLAIRE, et al.
Publicado: (2012)

AB175. The first large-scale study of VHL gene mutation spectrum and genotype-phenotype correlationship of VHL disease in China
por: Peng, Shuanghe, et al.
Publicado: (2015)

A Screening Approach for Inherited Erythrocytosis due to the VHL:c.598C > T Mutation (Chuvash Polycythemia)
por: Duggal, Nisha, et al.
Publicado: (2023)

Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
por: Szegedi, Krisztián, et al.
Publicado: (2023)

Identification of 3 novel VHL germ-line mutations in Danish VHL patients
por: Dandanell, Mette, et al.
Publicado: (2012)

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009)

Trichloroethylene exposure and somatic mutations of the VHL gene in patients with Renal Cell Carcinoma
por: Charbotel, Barbara, et al.
Publicado: (2007)

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
por: Albers, Joachim, et al.
Publicado: (2013)

Delayed Cardiac Metastasis from Renal Cell Carcinoma Caused by VHL Mutation
por: Sudduth, Christopher L., et al.
Publicado: (2023)

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma
por: Gemmill, R M, et al.
Publicado: (2005)

Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
por: Kondo, Keiichi, et al.
Publicado: (2003)

Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance
por: Razafinjatovo, Caroline, et al.
Publicado: (2016)

The VHL-dependent regulation of microRNAs in renal cancer
por: Neal, Calida S, et al.
Publicado: (2010)

VHL-deficiency leads to reductive stress in renal cells
por: Vellama, Hans, et al.
Publicado: (2023)

Expression of Von Hippel – Lindau (VHL) gene mutation in diagnosed cases of renal cell carcinoma
por: Shahzad, Humera, et al.
Publicado: (2014)

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes
por: Büscheck, Franziska, et al.
Publicado: (2020)

Genotype-Phenotype Correlation in Patients With Germline Mutations of VHL, RET, SDHB, and SDHD Genes: Thai Experience
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2017)

Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel–Lindau Disease
por: Hong, Baoan, et al.
Publicado: (2019)

The Most Common VHL Point Mutation R167Q in Hereditary VHL Disease Interferes with Cell Plasticity Regulation
por: Buart, Stéphanie, et al.
Publicado: (2021)

VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
por: Mathó, Cecilia, et al.
Publicado: (2022)

Deciphering von Hippel-Lindau (VHL/Vhl)-Associated Pancreatic Manifestations by Inactivating Vhl in Specific Pancreatic Cell Populations
por: Shen, H.-C. Jennifer, et al.
Publicado: (2009)

USP9X destabilizes pVHL and promotes cell proliferation
por: Zhang, Cong, et al.
Publicado: (2016)

Von Hippel-Lindau (VHL) Inactivation in Sporadic Clear Cell Renal Cancer: Associations with Germline VHL Polymorphisms and Etiologic Risk Factors
por: Moore, Lee E., et al.
Publicado: (2011)

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene
por: Wykoff, C C, et al.
Publicado: (2004)

A multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation
por: Bugalho, Maria João M, et al.
Publicado: (2006)

An integrated computational approach can classify VHL missense mutations according to risk of clear cell renal carcinoma
por: Gossage, Lucy, et al.
Publicado: (2014)

HIF2A germline–mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma
por: Liu, Qiuli, et al.
Publicado: (2017)

Combined Vhl, Trp53 and Rb1 mutation causes clear cell renal cell carcinoma in mice
por: Harlander, Sabine, et al.
Publicado: (2017)

Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α
por: Fan, Yang, et al.
Publicado: (2016)

Effects of siRNA silencing on the susceptibility of the fish cell line CHSE-214 to Yersinia ruckeri
por: Menanteau-Ledouble, Simon, et al.
Publicado: (2020)

New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations
por: Fagundes, Gustavo F C, et al.
Publicado: (2019)

Computational and Experimental Characterization of dVHL Establish a Drosophila Model of VHL Syndrome
por: Shmueli, Merav D., et al.
Publicado: (2014)

ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer
por: Chen, Ke, et al.
Publicado: (2015)

Loss of Von Hippel–Lindau (VHL) Tumor Suppressor Gene Function: VHL–HIF Pathway and Advances in Treatments for Metastatic Renal Cell Carcinoma (RCC)
por: Kim, Hyunho, et al.
Publicado: (2021)

Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma
por: Xie, Jun, et al.
Publicado: (2016)

Sensitivity of VHL mutant kidney cancers to HIF2 inhibitors does not require an intact p53 pathway
por: Stransky, Laura A., et al.
Publicado: (2022)

Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype–phenotype correlation and gene therapy perspective
por: Tong, Dali, et al.
Publicado: (2021)

Biostatistics of VHL-Gene Transfection in the Health Informatics Analysis of Renal Cell Carcinoma
por: Gong, Yunxiang, et al.
Publicado: (2022)

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma
por: Hu, Junhui, et al.
Publicado: (2023)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
por: Wang, Xuechun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vd6843hak55i5ij6oqqapa574d